Stay updated with breaking news from Oncomap Extra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PotNetwork (OTCMKTS:POTN – Get Rating) and Exact Sciences (NASDAQ:EXAS – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, risk, earnings, profitability, valuation, dividends and institutional ownership. Analyst Ratings This is a summary of current ratings and target […]
Equities analysts forecast that Exact Sciences Co. (NASDAQ:EXAS – Get Rating) will report sales of $498.48 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Exact Sciences’ earnings, with the lowest sales estimate coming in at $492.40 million and the highest estimate coming in at $505.50 million. Exact […]
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, today announced new data supporting its cancer tests and...
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, today announced new data supporting its cancer tests and...
MDxHealth (NASDAQ:MDXH – Get Rating) and Exact Sciences (NASDAQ:EXAS – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Profitability This table compares MDxHealth and Exact Sciences’ net margins, return […]